About
Cleo Diagnostics Ltd (AU:COV) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
CLEO Commences Kit Manufacturing Ahead of FDA Submission
Mar 31 2026
Sample Collection Completion for Pivotal US Clinical Trial
Mar 23 2026
CLEO Optimises Biomarker Panel Ahead of FDA Submission
Feb 25 2026
Appendix 4D and Half Yearly Accounts
Feb 18 2026
CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
Financials
Revenue
A$2.56 M
Market Cap
A$75.96 M
EPS
-0.03
Translate